Alembic Pharmaceuticals (NSE:APLLTD) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:APLLTD Alembic Pharmaceuticals Ltd NSE:APLLTD
85 GF Score
Price ₹814.10
GF Value ₹1,101.42
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

NSE:APLLTD
85GF Score
Alembic Pharmaceuticals Ltd NSE:APLLTD
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alembic Pharmaceuticals (NSE:APLLTD) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹814.10 is trading 26.1% below its estimated GF Value™ of ₹1,101.42. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:APLLTD:

  • Cash Payments:
  • GF Value™: ₹1,101.42 vs. price of ₹814.10 (26.1% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the NSE:APLLTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alembic Pharmaceuticals Business Description

Other Exchanges 533573:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
85GF Score

Get the complete analysis for NSE:APLLTD

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹814.10
Price
₹1,101.42
GF Value